NEW YORK (awp international) – At the end of a trading week marked by losses, investors on Wall Street have dared no more big leaps. The focus on Friday was on a number of mixed corporate reports on the past quarter.
The US benchmark index Dow Jones Industrial recently barely moved by minus 0.08 percent to 28,342.20 points. On a weekly basis, this indicates a decrease of around 1 percent.
The market-wide S&P 500 increased by 0.10 percent to 3456.87 points on Friday. The technology-heavy selection index Nasdaq 100 fell 0.45 percent to 11,610.4 points.
Investors are still waiting for positive signals for another corona aid package. The hope remains that a corresponding economic package could be announced before the presidential elections. Recently, however, the White House economic advisor Larry Kudlow was rather skeptical.
Meanwhile, there was positive news in the fight against the virus pandemic, because the US drug authority FDA had now approved the drug Remdesivir for the treatment of Covid-19 diseases. In addition, the German company Curevac, listed on the Nasdaq, published positive preclinical data for a vaccine candidate. Its shares rose by a good three percent.
Gilead’s shares benefited with a plus of almost two percent from the move by the FDA to approve Remdesivir against the lung disease Covid-19. So far, the drug has only had an emergency approval.
The Intel papers were the clear losers in the Dow with a minus of around eleven percent. The chip maker missed market expectations in its data center business last quarter.
The second weakest value in the US benchmark index were the shares of American Express, which lost more than two percent. Lower spending by credit card customers also weighed on the company in the third quarter
Mattel’s shares, on the other hand, soared by around 13 percent. Strong “Barbie” and “Hot Wheels” sales brought the toy manufacturer a strong profit jump./la/he
– .
